US HIV group spends 25% of time with viral load above 1500 copies

September 2015
HIV Treatment ALERTS!;Sep2015, p23
The article discusses the time spent by U.S. patients with human immunodeficiency virus (HIV) with viral load in receiving care. Topics covered include the importance of viral load to the transmission of the virus to other people. Also mentioned is the percentage of people who are receiving antiretroviral therapy.


Related Articles

  • History and origin of the HIV-1 subtype C epidemic in South Africa and the greater southern African region. Wilkinson, Eduan; Engelbrecht, Susan; de Oliveira, Tulio // Scientific Reports;11/20/2015, p16897 

    HIV has spread at an alarming rate in South Africa, making it the country with the highest number of HIV infections. Several studies have investigated the histories of HIV-1 subtype C epidemics but none have done so in the context of social and political transformation in southern Africa. There...

  • A Paradigm Shift: Focus on the HIV Prevention Continuum. McNairy, Margaret L.; El-Sadr, Wafaa M. // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue suppl_1, pS12 

    The human immunodeficiency virus (HIV) prevention continuum is a framework that illustrates the interconnectedness of each step in the spectrum of prevention services, while emphasizing that all steps are needed to decrease HIV acquisition and transmission. This continuum, similar to the HIV...

  • Early antiretroviral therapy reduces HIV-1 transmission risk to uninfected partners in sexually active couples.  // Formulary;Oct2011, Vol. 46 Issue 10, p402 

    The article reports on research which was conducted on antiretroviral therapy and was sponsored by the HIV Prevention Trials Network and The National Institute of Allergy and Infectious Disease. The research found that in sexually active partners, early treatment with antiretroviral therapy...

  • Strategies for Preventing Mucosal Cell-Associated HIV Transmission. Whaley, Kevin J.; Mayer, Kenneth H. // Journal of Infectious Diseases;Dec2014, Vol. 210 Issue suppl_3, pS674 

    Human immunodeficiency virus (HIV) may be transmitted through either cell-free virions or leukocytes harboring intracellular HIV in bodily fluids. In recent years, the early initiation of combination antiretroviral therapy leading to virological suppression has resulted in decreased HIV...

  • The Role of Cell-Associated Virus in Mother-to-Child HIV Transmission. Milligan, Caitlin; Overbaugh, Julie // Journal of Infectious Diseases;Dec2014, Vol. 210 Issue suppl_3, pS631 

    Mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) continues to contribute to the global burden of disease despite great advances in antiretroviral (ARV) treatment and prophylaxis. In this review, we discuss the proposed mechanisms of MTCT, evidence for cell-free and...

  • The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda. Baggaley, Rachel; Doherty, Meg; Ball, Andrew; Ford, Nathan; Hirnschall, Gottfried // Clinical Infectious Diseases;2015 Supplement, Vol. 60, pS159 

    There is a clear convergence toward an overarching strategic use of antiretroviral drugs to prevent human immunodeficiency virus (HIV) infection. Four interventions-immediate antiretroviral therapy (ART) for the infected partner in a serodiscordant couple, preexposure prophylaxis (PrEP),...

  • Antiretroviral Therapy May Lower HIV Transmission Risk Within Couples. Ball, H. // International Perspectives on Sexual & Reproductive Health;Sep2010, Vol. 36 Issue 3, p160 

    The article discusses a prospective cohort analysis reported by D. Donnell et al. in a 2010 issue of "Lancet" on HIV transmission risk within couples that include a partner receiving antiretroviral therapy. Study design and statistical findings are discussed. Antiretroviral therapy...

  • Protecting the Next Generation � Eliminating Perinatal HIV-1 Infection. Mofenson, Lynne M. // New England Journal of Medicine;6/17/2010, Vol. 362 Issue 24, p2316 

    In this article, the author expresses his views on the need for human immunodeficiency virus type 1 (HIV-1) infections to be eliminated. In Africa, there are incidents where HIV-1 infection is acquired through breast milk. He also offers information on the results of a study that focused on...

  • Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. Ingle, Suzanne M.; May, Margaret T.; Gill, M. John; Mugavero, Michael J.; Lewden, Charlotte; Abgrall, Sophie; Fätkenheuer, Gerd; Reiss, Peter; Saag, Michael S.; Manzardo, Christian; Grabar, Sophie; Bruyand, Mathias; Moore, David; Mocroft, Amanda; Sterling, Timothy R.; D'Arminio Monforte, Antonella; Hernando, Victoria; Teira, Ramon; Guest, Jodie; Cavassini, Matthias // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 2, p287 

    Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific death varied by ART duration and were strongly related to age, sex, and transmission risk group. Deaths from non-AIDS malignancies were much more frequent than those from cardiovascular...

  • The Effects of Fetal and Childhood Exposure to Antiretroviral Agents. Mas, Catherine M.; Miller, Tracie L.; Cordero, Christina; Dauphin, Danielle; White, Marie Boursiquot; Vila, Christie K.; Somarriba, Gabriel; Wilkinson, James D.; Lipshultz, Steven E. // Journal of AIDS & Clinical Research;Special2012, Vol. 3 Issue S, Special section p1 

    Purpose: The compliant use of combination antiretroviral therapy has virtually eliminated perinatal HIV transmission. Although antiretroviral drug toxicities in adults have been well documented, the effects of fetal and early childhood exposure to antiretroviral drugs on children of HIV-positive...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics